OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Demographic and clinical correlates of substance use disorders in first episode psychosis
Mary F. Brunette, Kim T. Mueser, Steven F. Babbin, et al.
Schizophrenia Research (2017) Vol. 194, pp. 4-12
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis
Glenn E. Hunt, Matthew Large, Michelle Cleary, et al.
Drug and Alcohol Dependence (2018) Vol. 191, pp. 234-258
Closed Access | Times Cited: 392

Unique Effects of Clozapine: A Pharmacological Perspective
Jibran Y. Khokhar, Angela M. Henricks, Emily D. K. Sullivan, et al.
Advances in pharmacology (2018), pp. 137-162
Open Access | Times Cited: 152

Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review
Deborah S. Hasin, Claire Walsh
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 87

Multivariate Associations Among Behavioral, Clinical, and Multimodal Imaging Phenotypes in Patients With Psychosis
Dominik A. Moser, Gaëlle E. Doucet, Won Hee Lee, et al.
JAMA Psychiatry (2018) Vol. 75, Iss. 4, pp. 386-386
Open Access | Times Cited: 86

Psychosocial interventions for people with both severe mental illness and substance misuse
Glenn E. Hunt, Nandi Siegfried, Kirsten C. Morley, et al.
Cochrane library (2019) Vol. 2019, Iss. 12
Open Access | Times Cited: 82

Alcohol Use Disorder and Schizophrenia and Schizoaffective� Disorders
Luke J. Archibald
Alcohol research (2019) Vol. 40, Iss. 1
Open Access | Times Cited: 73

A Neurodevelopment Approach for a Transitional Model of Early Onset Schizophrenia
Domenico De Berardis, Sergio De Filippis, Gabriele Masi, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 275-275
Open Access | Times Cited: 49

Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021
Deborah S. Hasin, Jacob T. Borodovsky, Dvora Shmulewitz, et al.
Addictive Behaviors (2023) Vol. 140, pp. 107617-107617
Open Access | Times Cited: 20

Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial
Corinne Cather, Mary F. Brunette, Kim T. Mueser, et al.
Psychiatry Research (2018) Vol. 268, pp. 303-311
Closed Access | Times Cited: 48

Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws
Deborah S. Hasin, Jacob T. Borodovsky, Dvora Shmulewitz, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109159-109159
Open Access | Times Cited: 34

Much of the Neurocognitive Impairment in Schizophrenia is Due to Factors Other Than Schizophrenia Itself: Implications for Research and Treatment
Steffen Moritz, Steven M. Silverstein, Thomas Beblo, et al.
Schizophrenia Bulletin Open (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 28

A systematic review of digital interventions for smoking cessation in patients with serious mental illness
Luis Martínez Agulleiro, Bhagyashree Patil, Joseph Firth, et al.
Psychological Medicine (2023) Vol. 53, Iss. 11, pp. 4856-4868
Open Access | Times Cited: 13

Motivation and Pleasure Deficits Undermine the Benefits of Social Affiliation in Psychosis
Jack J. Blanchard, Jason F. Smith, Melanie E. Bennett, et al.
Clinical Psychological Science (2024) Vol. 12, Iss. 6, pp. 1195-1217
Open Access | Times Cited: 4

Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort
Marco Colizzi, Natoy Burnett, Rosalia Costa, et al.
Psychiatry Research (2018) Vol. 268, pp. 381-387
Open Access | Times Cited: 33

Effects of khat use on response to antipsychotic medications in patients with newly diagnosed schizophrenia: a retrospective study
Tahir Hakami, Mahmoud Mahmoud, Barakat Mohammed, et al.
Eastern Mediterranean Health Journal (2021) Vol. 27, Iss. 4, pp. 353-360
Open Access | Times Cited: 27

Exposotypes in Psychotic Disorders
Walid Yassin, Bryan Kromenacker, James Green, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Socioenvironmental and Developmental Predictors of Cannabis Initiation and Use in Psychosis: a Systematic Scoping Review
Leda Kennedy, Jessica Lin, Vereena Metry, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Open Access

Prevalence, demographics and clinical characteristics of Internet addiction among Chinese adolescents with schizophrenia
Yunhui Zhong, Yibo Li, Anquan Hu, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3

Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program
Olivier Corbeil, Stéphanie Corbeil, Michel Dorval, et al.
CNS Drugs (2021) Vol. 35, Iss. 4, pp. 461-468
Closed Access | Times Cited: 19

A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness
Karolina Kozak, Philip H. Smith, Darby J. E. Lowe, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 5, pp. 535-547
Open Access | Times Cited: 19

The Ethics of Risk Prediction for Psychosis and Suicide Attempt in Youth Mental Health
William Smith, Paul S. Appelbaum, Matthew S. Lebowitz, et al.
The Journal of Pediatrics (2023) Vol. 263, pp. 113583-113583
Open Access | Times Cited: 8

Alcohol drinking in male patients with chronic schizophrenia: prevalence and its relationship to clinical symptoms
Menghan Lv, Xuan Wang, Zhiren Wang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 8

Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders
Laura B. Teal, Robert W. Gould, Andrew S. Felts, et al.
Advances in pharmacology (2019), pp. 153-196
Closed Access | Times Cited: 20

Pathways Through Early Psychosis Care for U.S. Youths From Ethnically and Racially Minoritized Groups: A Systematic Review
Neely Myers, Matthew Hutnyan, Tamara C. Daley, et al.
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 859-868
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top